Suppr超能文献

紧密连接蛋白4(Claudin-4)的表达可将SWI/SNF复合物缺陷型未分化癌与肉瘤区分开来。

Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.

作者信息

Schaefer Inga-Marie, Agaimy Abbas, Fletcher Christopher Dm, Hornick Jason L

机构信息

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital of Erlangen, Erlangen, Germany.

出版信息

Mod Pathol. 2017 Apr;30(4):539-548. doi: 10.1038/modpathol.2016.230. Epub 2017 Jan 13.

Abstract

Inactivation of SWI/SNF (switch/sucrose non-fermentable) chromatin remodeling complex subunits is a feature shared by select carcinomas and sarcomas with epithelioid morphology and variable keratin expression, making the distinction between carcinoma and sarcoma challenging in some cases. The tight junction-associated protein claudin-4 is a marker of epithelial differentiation that is expressed in nearly all carcinomas. Claudin-4 expression has been reported in the glandular component of biphasic synovial sarcoma but has not been systematically evaluated in other sarcoma types. In this study we assessed claudin-4 expression in SWI/SNF complex-deficient neoplasms showing loss of SMARCB1 (INI1), SMARCA4 (BRG1), or ARID1A and other sarcomas with epithelioid morphology. Immunohistochemistry for claudin-4 was performed on 130 neoplasms, including 90 soft tissue tumors with epithelioid morphology and/or SMARCB1 deficiency (20 epithelioid sarcomas (10 conventional, 10 proximal-type); 10 epithelioid angiosarcomas; 10 epithelioid hemangioendotheliomas; 15 epithelioid malignant peripheral nerve sheath tumors; 10 malignant rhabdoid tumors; 15 myoepithelial carcinomas; 10 biphasic synovial sarcomas), 10 ovarian clear cell carcinomas, 10 ovarian small cell carcinomas of hypercalcemic type, and 20 SWI/SNF complex-deficient undifferentiated carcinomas (14 SMARCB1 deficient and 6 SMARCA4 deficient, including rhabdoid carcinomas of various sites and sinonasal carcinomas). Membranous expression of claudin-4 (≥5% of cells) was observed in all biphasic synovial sarcomas (epithelial component only), all ovarian clear cell carcinomas, and 16 (80%) SWI/SNF complex-deficient undifferentiated carcinomas. All other soft tissue tumors were negative for claudin-4, with the exception of two myoepithelial carcinomas and one malignant rhabdoid tumor. Interestingly, none of the ovarian small cell carcinomas of hypercalcemic type expressed claudin-4. In summary, expression of claudin-4 is highly specific for true epithelial differentiation and may be useful to distinguish SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas with epithelioid morphology. The lack of claudin-4 expression in ovarian small cell carcinomas of hypercalcemic type suggests that these tumors may be better regarded as sarcomas rather than carcinomas.

摘要

SWI/SNF(开关/蔗糖非发酵)染色质重塑复合体亚基的失活是某些具有上皮样形态和可变角蛋白表达的癌和肉瘤的共同特征,这使得在某些情况下区分癌和肉瘤具有挑战性。紧密连接相关蛋白claudin-4是上皮分化的标志物,几乎在所有癌中均有表达。已有报道称claudin-4在双相滑膜肉瘤的腺性成分中表达,但尚未在其他肉瘤类型中进行系统评估。在本研究中,我们评估了claudin-4在显示SMARCB1(INI1)、SMARCA4(BRG1)或ARID1A缺失的SWI/SNF复合体缺陷性肿瘤以及其他具有上皮样形态的肉瘤中的表达情况。对130例肿瘤进行了claudin-4免疫组织化学检测,包括90例具有上皮样形态和/或SMARCB1缺陷的软组织肿瘤(20例上皮样肉瘤(10例经典型,10例近端型);10例上皮样血管肉瘤;10例上皮样血管内皮瘤;15例上皮样恶性外周神经鞘瘤;10例恶性横纹肌样瘤;15例肌上皮癌;10例双相滑膜肉瘤)、10例卵巢透明细胞癌、10例高钙血症型卵巢小细胞癌以及20例SWI/SNF复合体缺陷性未分化癌(14例SMARCB1缺陷和6例SMARCA4缺陷,包括不同部位的横纹肌样癌和鼻窦癌)。在所有双相滑膜肉瘤(仅上皮成分)、所有卵巢透明细胞癌以及16例(80%)SWI/SNF复合体缺陷性未分化癌中观察到claudin-4的膜性表达(≥5%的细胞)。所有其他软组织肿瘤claudin-4均为阴性,但有2例肌上皮癌和1例恶性横纹肌样瘤除外。有趣的是,高钙血症型卵巢小细胞癌均未表达claudin-4。总之,claudin-4的表达对真正的上皮分化具有高度特异性,可能有助于区分SWI/SNF复合体缺陷性未分化癌和具有上皮样形态的肉瘤。高钙血症型卵巢小细胞癌缺乏claudin-4表达提示这些肿瘤可能更应被视为肉瘤而非癌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验